On December 13th, Hannah Bazick successfully defended her PhD Thesis: “Towards an effective gene therapy for Angelman syndrome: Targeting Ube3a-ATS with CRISPR/Cas9 and zinc finger nucleases”. Mentor: Dr. Mark Zylka. Congratulations Dr. Bazick!!
On December 13th, Hannah Bazick successfully defended her PhD Thesis: “Towards an effective gene therapy for Angelman syndrome: Targeting Ube3a-ATS with CRISPR/Cas9 and zinc finger nucleases”. Mentor: Dr. Mark Zylka. Congratulations Dr. Bazick!!